Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 326 participants.
Also called NCT07034690
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 326 participants
- Sponsor
- Registry
-
NCT07034690
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Arab Emirates
- Registry status
- Recruiting
Technical summary
Registry record NCT07034690. Randomized; no masking; primary purpose other. Start 2025-11-26 (actual); primary completion 2027-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia
- Acronym
- OPTIMA
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Other)
- Educational Material
- Intervention (Other)
- Standard of care
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct07034690- Content hash
b58660518cf192c739ca213e810936d85e71fa2ff0906a02d3b6fd83013f3c63